The enhancement of apoptosis (increased cleaved caspase 3 and PARP1 levels) and reduction in tumor cell proliferation (decreased Ki67 and proliferating cell nuclear antigen (PCNA) levels) by VSV-S treatment were demonstrated by Western blot analysis of tumor tissues (Figure 2F). This evidence concerns the gene PARP1 and neoplasm.